BioAge Labs (BIOA) Non-Current Debt (2023 - 2025)

BioAge Labs has disclosed Non-Current Debt across 3 years of filings, most recently posting $1.1 million for Q1 2025.

• Non-Current Debt for Q1 2025 came in at $1.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $1.1 million (changed N/A YoY), and the FY2024 annual result was $2.5 million, down 69.49% from the prior year.
• Non-Current Debt came in at $1.1 million for Q1 2025 at BioAge Labs, down from $2.5 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $8.2 million in Q4 2023 to a low of $1.1 million in Q1 2025.
• The 3-year median for Non-Current Debt is $3.2 million (2024), against an average of $3.9 million.
• Peak annual rise in Non-Current Debt reached 69.49% in 2024, while the deepest fall reached 69.49% in 2024.
• BioAge Labs' Non-Current Debt stood at $8.2 million in 2023, then plunged by 69.49% to $2.5 million in 2024, then tumbled by 57.79% to $1.1 million in 2025.
• The last three Non-Current Debt figures came in at $1.1 million (Q1 2025), $2.5 million (Q4 2024), and $3.9 million (Q3 2024), per Business Quant data.